AuthorTopic: A New Chapter in the Science of Psychedelic Microdosing  (Read 362 times)

Offline azozeo

  • Master Chef
  • *****
  • Posts: 8651
    • View Profile
A New Chapter in the Science of Psychedelic Microdosing
« on: March 11, 2019, 01:19:16 PM »

A psychedelic photograph by the artist TV MooreMARK METCALFE / GETTY
The purported benefits of microdosing psychedelics are as numerous as the research is sparse. The technique, which involves ingesting small amounts of LSD, mushrooms, or other hallucinogenic drugs every three or four days, has made headlines for its popularity as a “productivity hack” among the Silicon Valley elite. But anecdotal endorsements of microdosing claim that the routine can lead to a whole variety of benefits, including heightened emotional sensitivity, athletic performance, and creativity; and relief from symptoms of anxiety, depression, OCD, PTSD, and chronic pain—all without resulting in any sort of trip.

In a lab setting, meanwhile, these effects have hardly been studied. Microdosing straddles a line between homeopathic remedy and experimental biohacking as a promising tool that hasn’t yet made its way through the clinical system’s rigorous checks and balances. Now a new study published Monday in the journal ACS Chemical Neuroscience provides the first biological evidence that psychedelic microdosing could have unique therapeutic effects that differ from the effects of a full dose.
I know exactly what you mean. Let me tell you why you’re here. You’re here because you know something. What you know you can’t explain, but you feel it. You’ve felt it your entire life, that there’s something wrong with the world.
You don’t know what it is but its there, like a splinter in your mind


Related Topics

  Subject / Started by Replies Last post
68 Replies
Last post October 22, 2012, 08:58:15 AM
by Bot Blogger
1 Replies
Last post September 18, 2013, 09:13:55 AM
by Surly1
2 Replies
Last post April 29, 2019, 06:12:48 PM
by azozeo